1 - 25 of 27 results for author:"Brunet S." in Literature citations
Results Customize
› Repeat search in UniProtKB (17)
| Cardiomyocytes from AKAP7 knockout mice respond normally to adrenergic stimulation. Jones B.W., Brunet S., Gilbert M.L., Nichols C.B., Su T., Westenbroek R.E., Scott J.D., Catterall W.A., McKnight G.S. Proc. Natl. Acad. Sci. U.S.A. 109:17099-17104(2012) · Mapped (11) |
| Error-prone mammalian female meiosis from silencing the spindle assembly checkpoint without normal interkinetochore tension. Kolano A., Brunet S., Silk A.D., Cleveland D.W., Verlhac M.H. Proc. Natl. Acad. Sci. U.S.A. 109:E1858-67(2012) · Mapped (19) |
| Adverse impact of IDH1 and IDH2 mutations in primary AML: experience of the Spanish CETLAM group. Nomdedeu J., Hoyos M., Carricondo M., Esteve J., Bussaglia E., Estivill C., Ribera J.M., Duarte R., Salamero O., Gallardo D. et al. Leuk. Res. 36:990-997(2012) · Mapped (13) |
| Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis. Brunet S., Labopin M., Esteve J., Cornelissen J., Socie G., Iori A.P., Verdonck L.F., Volin L., Gratwohl A., Sierra J. et al. J. Clin. Oncol. 30:735-741(2012) · Mapped (2) |
| Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia. Vazquez I., Maicas M., Cervera J., Agirre X., Marin-Bejar O., Marcotegui N., Vicente C., Lahortiga I., Gomez-Benito M., Carranza C. et al. Haematologica 96:1448-1456(2011) · Mapped (7) |
| C4orf41 and TTC-15 are mammalian TRAPP components with a role at an early stage in ER-to-Golgi trafficking. Scrivens P.J., Noueihed B., Shahrzad N., Hul S., Brunet S., Sacher M. Mol. Biol. Cell 22:2083-2093(2011) · UniProtKB (11) · Mapped (2) |
| HURP permits MTOC sorting for robust meiotic spindle bipolarity, similar to extra centrosome clustering in cancer cells. Breuer M., Kolano A., Kwon M., Li C.C., Tsai T.F., Pellman D., Brunet S., Verlhac M.H. J. Cell Biol. 191:1251-1260(2010) · Mapped (6) |
| Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens. Montesinos P., Rayon C., Vellenga E., Brunet S., Gonzalez J., Gonzalez M., Holowiecka A., Esteve J., Bergua J., Gonzalez J.D. et al. Blood 117:1799-1805(2011) · Mapped (4) |
| Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis. Villani A.C., Lemire M., Louis E., Silverberg M.S., Collette C., Fortin G., Nimmo E.R., Renaud Y., Brunet S., Libioulle C. et al. PLoS ONE 4:e7154-e7154(2009) · Mapped (10) |
| TRAPPC2L is a novel, highly conserved TRAPP-interacting protein. Scrivens P.J., Shahrzad N., Moores A., Morin A., Brunet S., Sacher M. |
| CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy. Perez-Garcia A., Brunet S., Berlanga J.J., Tormo M., Nomdedeu J., Guardia R., Ribera J.M., Heras I., Llorente A., Hoyos M. et al. Leukemia 23:486-491(2009) · Mapped (6) |
| Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications. Espinosa I., Briones J., Bordes R., Brunet S., Martino R., Sureda A., Sierra J., Prat J. Histopathology 53:441-449(2008) · Mapped (7) |
| K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML). Carnicer M.J., Lasa A., Buschbeck M., Serrano E., Carricondo M., Brunet S., Aventin A., Sierra J., Di Croce L., Nomdedeu J.F. Ann. Hematol. 87:819-827(2008) · Mapped (2) |
| PPARalpha-mediated remodeling of repolarizing voltage-gated K+ (Kv) channels in a mouse model of metabolic cardiomyopathy. Marionneau C., Aimond F., Brunet S., Niwa N., Finck B., Kelly D.P., Nerbonne J.M. J. Mol. Cell. Cardiol. 44:1002-1015(2008) · Mapped (2) |
| Mucolipidosis II: a single causal mutation in the N-acetylglucosamine-1-phosphotransferase gene (GNPTAB) in a French Canadian founder population. Plante M., Claveau S., Lepage P., Lavoie E.M., Brunet S., Roquis D., Morin C., Vezina H., Laprise C. Clin. Genet. 73:236-244(2008) · Mapped (5) |
| High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias. Lasa A., Serrano E., Carricondo M., Carnicer M.J., Brunet S., Badell I., Sierra J., Aventin A., Nomdedeu J.F. Ann. Hematol. 87:205-211(2008) · Mapped (7) |
| CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. Perez-Garcia A., De la Camara R., Roman-Gomez J., Jimenez-Velasco A., Encuentra M., Nieto J.B., de la Rubia J., Urbano-Ispizua A., Brunet S., Iriondo A. et al. Blood 110:461-467(2007) · Mapped (6) |
| Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia. Bolufer P., Collado M., Barragan E., Calasanz M.J., Colomer D., Tormo M., Gonzalez M., Brunet S., Batlle M., Cervera J. et al. Br. J. Haematol. 136:590-596(2007) · Mapped (49) |
| Abnormal hepatobiliary and circulating lipid metabolism in the Long-Evans Cinnamon rat model of Wilson's disease. Levy E., Brunet S., Alvarez F., Seidman E., Bouchard G., Escobar E., Martin S. Life Sci. 80:1472-1483(2007) · Mapped (6) |
| A systems biology analysis of the Drosophila phagosome. Stuart L.M., Boulais J., Charriere G.M., Hennessy E.J., Brunet S., Jutras I., Goyette G., Rondeau C., Letarte S., Huang H. et al. |
| Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia. Monzo M., Brunet S., Urbano-Ispizua A., Navarro A., Perea G., Esteve J., Artells R., Granell M., Berlanga J., Ribera J.M. et al. Blood 107:4871-4879(2006) · Mapped (55) |
| Group o human immunodeficiency virus type 1 infection that escaped detection in two immmunoassays. Zouhair S., Roussin-Bretagne S., Moreau A., Brunet S., Laperche S., Maniez M., Barin F., Harzic M. J. Clin. Microbiol. 44:662-665(2006) · UniProtKB (1) |
| Gamma-secretase is a functional component of phagosomes. Jutras I., Laplante A., Boulais J., Brunet S., Thinakaran G., Desjardins M. J. Biol. Chem. 280:36310-36317(2005) · Mapped (16) |
| Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Chiu H.C., Kovacs A., Blanton R.M., Han X., Courtois M., Weinheimer C.J., Yamada K.A., Brunet S., Xu H., Nerbonne J.M. et al. Circ. Res. 96:225-233(2005) · Mapped (4) |
| MEIS 1 expression is downregulated through promoter hypermethylation in AML1-ETO acute myeloid leukemias. Lasa A., Carnicer M.J., Aventin A., Estivill C., Brunet S., Sierra J., Nomdedeu J.F. Leukemia 18:1231-1237(2004) · Mapped (9) |